Mylan is committed to working with the Indian government to support its goal of eliminating Tuberculosis by 2025.
Recognized for its outstanding growth rate and contributions to India's Pharmaceutical Exports
Mylan enables access to safe drinking water at schools and supports solid waste management
Recognized as 'Brand of the Year' in Acute Therapy for its strategic and marketing excellence
In an endeavor to advance our efforts to address the unmet needs of the communities, Mylan Supports the Indian Institute of Liver and Digestive Sciences.
Mylan to work in 40 cities and collaborate with more than 2000 doctors to cater to the unmet medical needs of viral hepatitis patients in the state
Recognized by the Pharmaceuticals Export Promotion Council for its outstanding contribution to India’s Pharmaceutical Exports for 2017-18
More than 200 students and professionals collaborated with people at Mylan to innovate solutions that address real-world challenges
Mylan’s two API units in Vishakapatnam receive the prestigious five-star grading from the recent Five Star Occupational Health and Safety Audit conducted by the British Safety Council (BSC)
The close of Mylan’s deal to acquire Meda marks the beginning of another exciting chapter as we work to create better health for a better world.